Skip to content

Apotheek Anselmo: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apotheek Anselmo

BE 0463.455.607
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€25,688
2024 · €36,647-€10,960
Equity
€150,239
2024 · €125,051+€25,188
Cash
€51,887
2024 · €59,614-€7,728
Balance sheet total
€249,318
2024 · €253,961-€4,643

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€8,277

    down €8,277 (-13.5%), from €61,201 to €52,924

    of which Trade receivables: -€8,676

  • Stocks and contracts +€8,135

    up €8,135 (+7.3%), from €111,913 to €120,048

  • Cash -€7,728

    down €7,728 (-13.0%), from €59,614 to €51,887

    mainly Current portion of long-term debt (-€17,100) and Stocks and contracts (-€8,135)

Equity and liabilities
  • Reserves +€25,188

    up €25,188 (+20.8%), from €121,186 to €146,373

  • Current portion of long-term debt -€17,100

    down €17,100 (-75.0%), from €22,800 to €5,700

  • Other debts -€5,709

    down €5,709 (-13.5%), from €42,231 to €36,521

  • Debts after one year -€5,700

    down €5,700 (-100%), from €5,700 to €0

  • Trade debts -€4,957

    down €4,957 (-10.6%), from €46,754 to €41,797

Income statement
  • Staff costs +€6,616

    up €6,616 (+9.9%), from €66,702 to €73,318

  • Gross operating margin -€5,156

    down €5,156 (-4.3%), from €120,946 to €115,790

  • Taxes -€2,281

    down €2,281 (-21.9%), from €10,395 to €8,113

  • Depreciation +€1,739

    up €1,739 (+70.2%), from €2,478 to €4,216

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €36,647
Gross operating margin -€5,156
Staff costs -€6,616
Depreciation -€1,739
Other operating charges -€31
Financial income +€11
Financial charges +€291
Taxes +€2,281
Result 2025 €25,688
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€20,817
Investment -€5,244
Financing -€23,300
Cash 2024 €59,614
Net result for the year +€25,688
Depreciation +€4,216
Stocks and contracts -€8,135
Receivables within one year +€8,277
Deferred charges and accrued income -€2,199
Trade debts -€4,957
Tax, wage and social debts -€322
Other debts -€5,709
Accrued charges and deferred income +€3,958
Investment in fixed assets (net) -€5,244
Debts after one year -€5,700
Current portion of long-term debt -€17,100
Contributions, distributions and other -€500
Cash 2025 €51,887
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €253,961 €249,318 -€4,643 -1.8%
Fixed assets 21/28 €9,343 €10,371 +€1,028 +11.0%
Tangible fixed assets 22/27 €9,343 €10,371 +€1,028 +11.0%
Plant, machinery and equipment 23 €9,343 €9,545 +€202 +2.2%
Furniture and vehicles 24 - €826 +€826
Current assets 29/58 €244,618 €238,948 -€5,671 -2.3%
Stocks and contracts in progress 3 €111,913 €120,048 +€8,135 +7.3%
Stocks 30/36 €111,913 €120,048 +€8,135 +7.3%
Amounts receivable within one year 40/41 €61,201 €52,924 -€8,277 -13.5%
Trade receivables 40 €58,781 €50,105 -€8,676 -14.8%
Other amounts receivable 41 €2,420 €2,819 +€399 +16.5%
Cash at bank and in hand 54/58 €59,614 €51,887 -€7,728 -13.0%
Deferred charges and accrued income 490/1 €11,890 €14,089 +€2,199 +18.5%
Total equity and liabilities 10/49 €253,961 €249,318 -€4,643 -1.8%
Equity 10/15 €125,051 €150,239 +€25,188 +20.1%
Contributions 10/11 €3,865 €3,865 = 0.0%
Reserves 13 €121,186 €146,373 +€25,188 +20.8%
Distributable reserves 133 €121,186 €146,373 +€25,188 +20.8%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €128,910 €99,080 -€29,830 -23.1%
Amounts payable after more than one year 17 €5,700 €0 -€5,700 -100%
Financial debts 170/4 €5,700 €0 -€5,700 -100%
Amounts payable within one year 42/48 €123,210 €95,122 -€28,088 -22.8%
Current portion of amounts payable after more than one year 42 €22,800 €5,700 -€17,100 -75.0%
Trade debts 44 €46,754 €41,797 -€4,957 -10.6%
Suppliers 440/4 €46,754 €41,797 -€4,957 -10.6%
Taxes, remuneration and social security 45 €11,425 €11,103 -€322 -2.8%
Taxes 450/3 €1,395 €1,530 +€135 +9.7%
Remuneration and social security 454/9 €10,030 €9,573 -€457 -4.6%
Other amounts payable 47/48 €42,231 €36,521 -€5,709 -13.5%
Accrued charges and deferred income 492/3 €0 €3,958 +€3,958
Remuneration, social security and pensions 62 €66,702 €73,318 +€6,616 +9.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,478 €4,216 +€1,739 +70.2%
Other operating charges 640/8 €460 €492 +€31 +6.8%
Gross operating margin 9900 €120,946 €115,790 -€5,156 -4.3%
Operating profit (loss) 9901 €51,306 €37,763 -€13,542 -26.4%
Financial income 75/76B €0 €11 +€11
Recurring financial income 75 €0 €11 +€11
Financial charges 65/66B €4,264 €3,973 -€291 -6.8%
Recurring financial charges 65 €4,264 €3,973 -€291 -6.8%
Profit (loss) for the period before taxes 9903 €47,042 €33,801 -€13,241 -28.1%
Income taxes 67/77 €10,395 €8,113 -€2,281 -21.9%
Profit (loss) for the period 9904 €36,647 €25,688 -€10,960 -29.9%
Profit (loss) for the period to be appropriated 9905 €36,647 €25,688 -€10,960 -29.9%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.